Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | HY-16462 |
Trade Name | |
Synonyms | HY16462|HY 16462 |
Drug Descriptions |
HY-16462 is a CDK9 inhibitor, which has potential antitumor activity (PMID: 31000582). |
DrugClasses | CDK9 Inhibitor 21 |
CAS Registry Number | 1263369-28-3 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
CPI-637 + HY-16462 | CPI-637 HY-16462 | 0 | 0 |
GSK2801 + HY-16462 | GSK2801 HY-16462 | 0 | 0 |
HY-16462 | HY-16462 | 0 | 0 |
HY-16462 + JQ1 | HY-16462 JQ1 | 0 | 0 |